Table 1.

HLA-G expression detected with mAbs 4H84 and 5A6G7 related to the clinical parameters in CRC patients.

Variables	Cases	HLA-G (mAb 4H84)			HLA-G(mAb 5A6G7)
		Neg.	Pos. (%)	p*	Neg.	Pos. (%)	p*
Gender
Male	214	69	145 (67.8%)	0.150	95	119 (55.6%)	0.329
Female	165	42	123 (74.5%)		65	100 (60.6%)
Age
≤ median (66 ys)	188	52	136 (72.3%)	0.490	78	110 (58.5%)	0.776
>median	191	59	132 (69.1%)		82	109 (57.1%)
TNM stage
Tumor status
T1+2	108	26	82 (75.9%)	0.016	39	69 (63.9%)	0.110
T3	256	79	177 (69.1%)		117	139 (54.3%)
T4	15	6	9 (60.0%)		4	11 (73.3%)
Nodal status
N0	201	57	144 (71.6%)	0.870	82	119 (59.2%)	0.421
N1	109	34	75 (68.8%)		44	65 (54.3%)
N2	69	20	49 (71.0%)		34	35 (73.3%)
Metastasis status
M0	368	110	258 (70.1%)	0.135	156	212 (57.6%)	0.690
M1	11	1	10 (90.9%)		4	7 (63.6%)
Disease stage
I	85	23	62 (72.9%)	0.434	28	57 (67.1%)	0.207
II	114	34	80 (70.2%)		54	60 (52.6%)
III	169	53	116 (68.6%)		74	95 (56.2%)
IV	11	1	10 (90.9%)		4	7 (63.6%)

^*Comparison of HLA-G expression status between or among each variable using the Pearson chi-square test. TNM, lymph-node-metastasis and stage according to the TNM classification.